Krohne, Tim U <br/><br/>
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.  [electronic resource] 

 -  American journal of ophthalmology  Oct 2008 
 - 508-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2008.05.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized<br/>Aqueous Humor--metabolism<br/>Bevacizumab<br/>Cataract--complications<br/>Cataract Extraction<br/>Diabetic Retinopathy--complications<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Half-Life<br/>Humans<br/>Injections<br/>Macular Degeneration--complications<br/>Macular Edema--etiology<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Retinal Vein Occlusion--complications<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vitreous Body